• Praeruptorin A Suppresses HCC Metastasis via ERK/MMP1 Modula

  2026-05-25

  This study demonstrates that Praeruptorin A, an angular pyranocoumarin compound, inhibits migration and invasion of hepatocellular carcinoma (HCC) cells by targeting the ERK/MMP1 signaling axis. These findings provide mechanistic evidence for Praeruptorin A’s potential as an antimetastatic agent in advanced HCC research and model systems.

• Annexin V-PE: Shaping Translational Apoptosis Research Front

  2026-05-24

  Explore how mechanistic insights into phosphatidylserine externalization and advanced apoptosis assays are transforming translational research. This article synthesizes recent evidence on cell death pathways with strategic recommendations for leveraging the Annexin V-PE Apoptosis Detection Kit in disease modeling and therapeutic evaluation, providing protocol guidance and a forward-looking perspective for cell biologists and clinicians.

• 5-hme-dCTP: Modified Nucleotide for Epigenetic DNA Research

  2026-05-23

  5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate) enables precise mapping of 5-hydroxymethylcytosine in DNA. It supports high-fidelity studies of epigenetic regulation, especially in plant stress response. APExBIO's B8113 product provides ≥90% purity for robust experimental reproducibility.

• TGF-β Regulation of Sca-1 and Plasticity in Mammary Stem Cel

  2026-05-22

  This study uncovers how TGF-β signaling modulates Sca-1 expression and cellular plasticity in pre-neoplastic mammary epithelial stem cells, revealing critical pathways in the maintenance of stemness and tumorigenic potential. The findings offer mechanistic insight into how TGF-β-driven signaling influences the emergence and behavior of tumor-initiating cell populations.

• CXCR4-Targeted Imaging and Therapy in Lymphoma: Advances and

  2026-05-22

  This review details recent advances in CXCR4-targeted imaging and therapeutic strategies for lymphoma, emphasizing the receptor's role in tumor aggressiveness and therapy resistance. It highlights the integration of molecular imaging and ligand-based interventions, shaping precision oncology approaches.

• Efficacy and Safety of Elbasvir/Grazoprevir in HCV Genotypes

  2026-05-21

  This article analyzes the 2021 review by Wang et al., which evaluates the pharmacology, efficacy, and safety of the elbasvir/grazoprevir regimen for hepatitis C virus (HCV) infection. The findings highlight robust, sustained virological response rates, especially in challenging patient cohorts, and discuss the regimen's pharmacokinetic advantages and tolerability.

• Carfilzomib (PR-171): Multi-Modal Cell Death in Tumor Models

  2026-05-21

  Explore Carfilzomib (PR-171) as a next-generation proteasome inhibitor uniquely capable of orchestrating apoptosis, paraptosis, and ferroptosis in cancer research. This article reveals new mechanistic insights and protocol parameters, directly informed by recent breakthroughs.

• Cyclic di-GMP: Redefining Biofilm Stability and Immune Modul

  2026-05-20

  Cyclic di-GMP is rapidly transforming the way we understand and manipulate bacterial biofilms and innate immune pathways. Drawing on recent mechanistic advances—including its antitoxin role in biofilm genome stability and its direct activation of the STING pathway—this article offers translational researchers actionable strategies for leveraging cyclic di-GMP across infection biology and cancer immunotherapy. With protocol guidance, evidence integration, and a critical look at product selection, this thought-leadership piece bridges mechanistic insight and translational vision.

• N6-Methyl-dATP: Next-Gen Epigenetic Insights for Translation

  2026-05-20

  This thought-leadership article explores the mechanistic impact, experimental validation, and translational potential of N6-Methyl-dATP. It contextualizes the analog’s role in dissecting DNA replication fidelity and epigenetic regulation, with direct reference to AML pathogenesis and the LMO2/LDB1 axis. Practical protocol guidance and cross-domain perspectives round out a strategic roadmap for researchers seeking to bridge bench discoveries with clinical innovation.

• BCECF-AM: Precision pH Sensing and Secretory Pathways in Pla

  2026-05-19

  Explore the advanced use of BCECF-AM as a cell-permeable fluorescent dye for precise intracellular pH measurement, with a deep dive into its mechanism and application in dissecting plant protein secretion pathways. This article uniquely bridges molecular probe chemistry and practical assay choices for plant cell research.

• Starvation, ER-Ca2+-Calpain Axis, and Cell Fate in Bombyx mo

  2026-05-19

  This study uncovers how sustained starvation in Bombyx mori fat body triggers a switch from autophagy to apoptosis through ER-Ca2+-calpain signaling. It also demonstrates the effectiveness of 2-APB as an IP3R antagonist in dissecting calcium-dependent programmed cell death, providing mechanistic clarity for researchers studying metabolic stress and intracellular calcium dynamics.

• Simvastatin (Zocor) in Advanced Cancer and Lipid Research Wo

  2026-05-18

  Simvastatin (Zocor) from APExBIO stands out for its dual utility as a cholesterol-lowering agent and a potent apoptosis inducer in liver cancer models. This guide translates literature-backed workflows and troubleshooting strategies into practical, reproducible research outcomes.

• PTT and CD47 Blockade Synergize via ECM Remodeling in OSCC

  2026-05-18

  This study demonstrates that combining photothermal therapy (PTT) with CD47 blockade in oral squamous cell carcinoma (OSCC) enhances anti-tumor immunity by promoting calreticulin exposure and remodeling the tumor extracellular matrix. These mechanistic insights offer a new approach to overcoming immune evasion and stromal barriers in solid tumors.

• AO/PI Double Staining Kit: Practical Cell Viability Assay Gu

  2026-05-17

  The AO/PI Double Staining Kit enables rapid and reliable discrimination of viable, apoptotic, and necrotic cells using dual fluorescent staining. It is best applied in cell viability and cell death assays across diverse cell types, but should not be used for applications requiring single-dye specificity or in settings lacking fluorescence microscopy capabilities.

• Bufuralol Hydrochloride: Enabling Next-Gen Cardiovascular Mo

  2026-05-16

  Explore how Bufuralol hydrochloride, a non-selective β-adrenergic receptor antagonist with partial intrinsic sympathomimetic activity, is transforming cardiovascular pharmacology research. This article bridges mechanistic insight, advanced hiPSC-derived intestinal organoid models, and translational strategy—providing actionable guidance for researchers using APExBIO’s Bufuralol hydrochloride to accelerate β-adrenergic modulation studies and overcome key pharmacokinetic challenges.

466 records 18/32 page Previous Next First page 上5页 1617181920 下5页 Last page